Manitoba Health
To view PDF files, you must have a copy of the Adobe Acrobat Reader which is available as a free download.
Drug Benefits & Interchangeability Formulary
The Manitoba Drug Benefits and Interchangeability Formulary lists therapeutically effective drugs of proven high quality that have been approved as eligible benefits under the Pharmacare drug benefit program. It also includes a list of interchangeable drugs. It is compiled with the recommendations of the Common Drug Review and the advice of the Manitoba Drug Standards and Therapeutics Committee, assisted by Manitoba Health staff. The Minister of Health gives the final approval for benefits under the Pharmacare drug benefit program.
Each new edition of the Formulary has three components:
- a new Bulletin,
- a revised Specified Drugs Regulation (Parts 1 and 2) made under The Prescription Drugs Cost Assistance Act ,
- and a revised Manitoba Drug Interchangeability Formulary.
A listing of pharmaceutical manufacturer abbreviations is also provided below.
These documents require knowledgeable interpretation and are intended primarily for use by professional health care practitioners, pharmacies, hospitals, and organizations associated with the manufacture, distribution and use of pharmaceutical preparations.
Bulletin #68 
Amendments to the Manitoba Drug Benefits and Interchangeability Formulary.
Effective: May 24, 2012
Specified Drugs Regulation
This is the regulation that provides for the benefit lists of specified drugs under the Prescription Drugs Cost Assistance Act. It lists the drugs and criteria for eligibility for the Manitoba Pharmacare program.
Effective: May 24, 2012
Manitoba Drug Interchangeability Formulary Regulation
This regulation under The Pharmaceutical Act includes a list of interchangeable drugs, categories and prices. Please note that Manitoba Pharmacare will reimburse only up to the lowest price in an interchangeable category for those interchangeable drugs which are Pharmacare benefits.
Effective: May 24, 2012
Part 3: Exception Drug Status (EDS)
Certain drugs are approved for coverage under the Exception Drug Status (EDS) Program when the use meets specific criteria as recommended by the Manitoba Drug Standards and Therapeutics Committee (MDSTC).
Revised: May 24, 2012
Manufacturer Abbreviations
An index of pharmaceutical manufacturer abbreviations used in the Manitoba Drug Interchangeability Formulary.
Revised: November 2011
Product Identification Number listing
A product identification listing for non-prescription products.
Revised: November 2011
(Veuillez noter que les documents sont offert en anglais seulement.)
For more information, please contact: |
Provincial Drug Programs |
